Print（PDF/119KB） Nov. 11, 2016 Corporate
Sumitomo Dainippon Pharma announces Organizational Realignment and Changes Related to Officers and Other Key Positions
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and changes related to its officers and other key positions, effective December 1, 2016:
I. Organizational Realignment (effective December 1, 2016)
Corporate Departments
Regenerative & Cellular Medicine Kobe Center is created.
The facility name “Kobe Regenerative & Cellular Medicine Center” is renamed to “Regenerative & Cellular Medicine Kobe Center” in accordance with the creation of Regenerative & Cellular Medicine Kobe Center.
II. Changes in Executive Officers
| Post as of December 1, 2016 | Current post | Name |
|---|---|---|
| Member, Board of Directors, Executive officer Senior Director, Global Corporate Planning; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center | Member, Board of Directors, Executive officer Senior Director, Global Corporate Planning; Regenerative & Cellular Medicine Office | Toru Kimura |
III. Changes in Personnel (effective December 1, 2016)
| Position as of December 1, 2016 | Current position | Name |
|---|---|---|
| Senior Director, Regenerative & Cellular Medicine Kobe Center | Director, Tissue Engineering Group, Regenerative & Cellular Medicine Office | Akiyoshi Kishino |
| Position as of December 1, 2016 | Current position | Name |
|---|---|---|
| Senior Director, Regulatory Compliance & Quality Assurance Management | Senior Director, Technology Research & Development Management | Yuko Uenishi |
| Position as of December 1, 2016 | Current position | Name |
|---|---|---|
| Deputy Executive Director, Technology Research & Development Division Senior Director, Technology Research & Development Management |
Deputy Executive Director, Technology Research & Development Division | Kazuhiko Takahashi |
Inquiries from the Press